The current lack of transparency in clinical trials threatens progress on the Sustainable Development Goals' health objectives. Unreported and misreported clinical trial outcomes result in the misallocation of public health funds, reduced pandemic preparedness, and a slowdown in the development of new vaccines, treatments and cures. Donors can strengthen trial transparency by promoting the adoption and implementation of the World Health Organization's best practices, rescuing unreported trial results from the global pile of research waste, and supporting transparency initiatives.

Recent CMI publications: